Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release▲ PositiveResults20 Aug 2026

Manipal Health Enterprises Limited

Press Release

Manipal Health Enterprises Limited announced its Q1 FY27 financial results, reporting 38.1% revenue growth and 26.4% EBITDA growth, driven by sustained patient demand, growth in high-acuity specialties, and capacity absorption.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults20 Aug 2026

LG Electronics India Ltd

Transcript of Earnings Call

LG Electronics India Ltd's Q1 FY2027 earnings conference call transcript reveals a 15.5% year-on-year revenue growth with EBITDA margin at 12.5%, up 1.1 percentage point year-on-year and 0.8 percentage point sequentially. The company's growth and profitability exceeded market expectations, with every key category operating in double digits.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults20 Aug 2026

LG Electronics India Limited

Analysts/Institutional Investor Meet/Con. Call Updates

LG Electronics India Limited has informed the Exchange about the transcript of the earnings call for the quarter ended June 30, 2026, which was scheduled on August 14, 2026. The company's senior management presented the financial results, highlighting a 15.5% year-on-year revenue growth and an EBITDA margin of 12.5%, up 1.1 percentage point year-on-year and 0.8 percentage point sequentially.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults20 Aug 2026

Zota Health Care LImited

Analysts/Institutional Investor Meet/Con. Call Updates

Zota Health Care Limited has informed the Exchange about the Transcript of Earnings Conference Call on financial results for the quarter ended June 30, 2026. The company has delivered robust growth across its operations, supported by a sustained expansion of the Davaindia Network and increasing consumer acceptance of affordable healthcare solutions. The company has added 264 new Davaindia stores, taking its total store strength to 2,825 stores across the country as of June 30, 2026. The company has also increased its investment in Davaindia Health Mart Limited through a right issue, further reinforcing its commitment towards scaling India's largest organized private-label pharmacy platform.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults20 Aug 2026

Voltas Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Voltas Limited has informed the Exchange about the transcript of the Q1 FY27 Earnings Conference Call held on 14th August, 2026. The company delivered a strong performance in Q1 FY27, significantly outperforming competition and further strengthening its leadership in the cooling segment.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults20 Aug 2026

Alkem Laboratories Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Alkem Laboratories Limited has announced its Q1 FY2027 earnings, with revenue from operations at INR3,740 crores, a 11% year-on-year growth, and EBITDA margin at 20.5%, a 3.7% year-on-year growth. The company has outperformed the Indian pharmaceutical market in 7 key focus therapies, with growth rates ranging from 1.1x to 1.6x.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults20 Aug 2026

Indo Count Industries Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Indo Count Industries Limited has announced its Q1 FY27 earnings, with a strong start to the year, achieving several important milestones, including highest ever quarterly revenue and rapid scale-up of new business, which has nearly tripled over the past one year. The company's EBITDA margin is on a recovery trajectory, supported by improving operating leverage and better volumes across the business.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults20 Aug 2026

Indo Count Industries Ltd

Transcript of Investors Conference Call held on 13th August, 2026 for Q1 FY27

Indo Count Industries Ltd announced its Q1 FY27 earnings, with a strong start to the year, achieving highest ever quarterly revenue and rapid scale-up of new business, nearly tripling over the past year. EBITDA margin is on a recovery trajectory, supported by improving operating leverage and better volumes across the business. U.S. manufacturing operations performed well, with utilization remaining around 60-65% despite the addition of a new greenfield facility.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults20 Aug 2026

Sigachi Industries Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Sigachi Industries Limited has informed the Exchange about the transcript of the earnings call for Q1 FY 2026-27 results. The company's Managing Director and Chief Executive Officer, Mr. Amit Raj Sinha, discussed the financial results and operational highlights of the quarter. The company reported total operating income of INR121.27 crores, EBITDA of INR16.5 crores, and net profit of INR8.14 crores. The company also launched a new product, HiCel SMCC Nutra, and continues to strengthen its governance, safety, and ESG practices.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults20 Aug 2026

Shanti Gold International Ltd

Earnings Call Transcript - Q1FY27

Shanti Gold International Ltd reported Q1 FY27 earnings, with revenue from operations increasing 144.69% to INR716.38 crores, and EBITDA margin expanding to 9.97%. The company's new manufacturing facility in Marol, Mumbai, has commenced operations, enhancing its manufacturing capabilities and flexibility.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults20 Aug 2026

Pritika Auto Industries Ltd

Dear Sir/Madam, With reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Investor Presentation on the ....

Pritika Auto Industries Ltd has submitted an investor presentation for Q1 FY27, highlighting a 26.5% year-on-year growth in revenue to ₹144.97 crore, with a 4.7% sequential increase. The company has received an order from KION USA and achieved its highest-ever monthly dispatch in July 2026.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults20 Aug 2026

Pritika Auto Industries Limited

Investor Presentation

Pritika Auto Industries Limited has submitted an investor presentation for Q1 FY27, highlighting a 26.5% year-on-year revenue growth and a 4.7% sequential increase, with a strong operational milestone achieved in July 2026.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults20 Aug 2026

Anupam Rasayan India Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Anupam Rasayan India Limited has announced its Q1 FY27 earnings, with a 36% year-on-year growth in consolidated total income. The company has commercialized Ethyl Trifluoroacetate (ETFA) using flow chemistry, signed a Letter of Intent with BASQUEVOLT, and made progress on the proposed acquisition of Bliss GVS Pharma.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults20 Aug 2026

Jeena Sikho Lifecare Ltd

Press Release titled JSLL Shares Update on IPD Growth and Business Mix

Jeena Sikho Lifecare Ltd has announced its Q1 FY27 results, with revenue from operations growing 29% YoY to ₹224.4 crore, driven by private-pay Panchakarma hospitalisation, at-centre medicine sales, and digital/e-commerce medicine channel. The company has also provided an update on its IPD growth, business mix, and operating performance.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults20 Aug 2026

Jeena Sikho Lifecare Limited

Press Release

Jeena Sikho Lifecare Limited has announced its Q1 FY27 financial results, with revenue from operations increasing 29% YoY to ₹224.4 crore. The company's private-pay Panchakarma hospitalisation, at-centre medicine sales, and digital/e-commerce medicine channel drove growth. The company has also provided an update on its IPD growth, business mix, and operating performance.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults20 Aug 2026

Anupam Rasayan India Ltd

Submission of transcript of earnings call on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.

Anupam Rasayan India Ltd has submitted the transcript of its earnings call for Q1 FY27, which saw a 36% YoY growth in consolidated total income. The company highlighted its commercialization of new products, healthy demand across key segments, and strategic initiatives such as the Jayhawk acquisition and proposed acquisition of Bliss GVS Pharma.

Read more →📎 1 attachment
← PreviousPage 257 of 519Next →